SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

ChemoCentryx Q1 EPS $(0.350) Misses $(0.300) Estimate, Sales $6.008M Miss $8.750M Estimate

ChemoCentryx (NASDAQ:CCXI) reported quarterly losses of $(0.350) per share which missed the analyst consensus estimate of $(0.300) by 16.67 percent. This is a 52.17 percent decrease over losses of $(0.230) per share from

Benzinga · 05/11/2020 20:24

ChemoCentryx (NASDAQ:CCXI) reported quarterly losses of $(0.350) per share which missed the analyst consensus estimate of $(0.300) by 16.67 percent. This is a 52.17 percent decrease over losses of $(0.230) per share from the same period last year. The company reported quarterly sales of $6.008 million which missed the analyst consensus estimate of $8.750 million by 31.34 percent. This is a 27.85 percent decrease over sales of $8.327 million the same period last year.